I just returned from a pharmacy education program this evening. I had the chance to discuss SCRC and MAP with a couple of the pharmacist there who do compounding pharmacy. I mentioned MAP generated $1.6M in revenues and the one pharmacist asked me if that was for one year. When I told him it was just for the month of May he almost fell off his chair. He couldn't believe it. We have in our grasp a real gold mine here. As many have posted here this evening, SCRC is just now beginning to show its strength. The future is very bright for all those smart enough to buy at these low prices. As Bsav posted a few days ago SCRC should report over $4M in revenues for Q2. And, that's just the beginning. Let's all get ready to fall off our chairs.